Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
20 Cards in this Set
- Front
- Back
what is the term for "stop bleeding"
|
hemostasis
|
|
what are the 3 hemostatic mechanisms
|
1. formation of a platelet plug (thrombus)
2. production of web of fibrin proteins that penetrates and surround the platelet plug 3. vasoconstriction |
|
what is another name for platelets
|
thrombocytes
|
|
do platelets have a nucleus?
|
no
|
|
platelets are made by pinching off pieces of specialized bone marrow cells called....
|
megakaryocytes
|
|
what is the average life span of a platelet?
|
5- 9 days
|
|
what is normal platelet count per cubic millimeter
|
130,000- 400,000 platelets
|
|
what are the 2 inhibitors that the endothelium releases that inhibit platelet aggregation
|
nitric oxide (NO) and prostacyclin (PGI2)
|
|
what is the enzyme expressed on endothelial cells that breaks ATP down to AMP
|
CD39
|
|
when platelets stick to collagen and vWF, change shape and release ADP, serotonin, and thromboxane A2. This is called....
|
platelet release reaction
|
|
this irreversibly inhibits the enxyme that synthesized thromboxane A2 in the platelets reducing the stimulus for platelet activation and the likelyhood of a MI
|
daily low dose aspirin
|
|
this blocks the platelet ADP receptor- inhibiting platelet activation
|
clopidogrel (Plavix)
|
|
what are the activators in the extrinsic pathway
|
tissue factor (thromboplastin)
|
|
what are the activators in the intrinsic pathway
|
collagen and negatively charged surface
|
|
which pathway is fast or slow?
|
extrinsic
|
|
an X-linked recessive trait prevalent in the Royal families of europe.
- due to defect in a subunit of factor VIII - results in reduced clotting- increased bleeding |
hemophilia A
|
|
a defective vWF results in poorer binding of platelets to the subendothelium and vWf also preotects clotting factor VIII
- results in reduced clotting- icreased bleeding |
Von Willebrand's disease
|
|
a type of anticoagulant that prevents clotting by activating a natural anticoagulant in the blood called antithrombin
|
heparin
|
|
type of anticoagulant that prevents clotting by inhibiting the synthesis of vitamin K dependent clotting factors
|
warfarin
|
|
after a clot forms, this circulating substance coats the fibrin meshwork
|
plasminogen
|